Travere Therapeutics, Inc.

8-K Director or officer change Jul 9, 2026 8-K Director or officer change Jun 16, 2026 8-K Entered a material agreement Jun 2, 2026 8-K Director or officer change; Shareholder vote results May 21, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events May 11, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) May 4, 2026 8-K Other events Apr 14, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Results of operations (earnings release) Feb 19, 2026 8-K Other events Jan 13, 2026 8-K Results of operations (earnings release) Jan 12, 2026 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Other events Sep 10, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change; Shareholder vote results May 16, 2025 8-K Other events May 15, 2025 8-K/A Results of operations (earnings release) May 1, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Completed an acquisition or disposition May 1, 2025 8-K Other events Apr 30, 2025 8-K Other events Mar 17, 2025 10-K Fiscal year ended 2024-12-31 Feb 21, 2025 8-K Results of operations (earnings release) Feb 20, 2025 8-K Other events Feb 11, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Other events Nov 8, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 8-K Other events Sep 26, 2024 8-K Other events Sep 6, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Director or officer change; Shareholder vote results May 13, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release) May 6, 2024 8-K Other events Apr 24, 2024 8-K Other events Feb 23, 2024